Cell Guidance Systems — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Cell Guidance Systems is a privately held, revenue-generating tools and services company providing essential research reagents and platforms to the life science sector. Its technology portfolio is strategically focused on high-growth areas like extracellular vesicle research and 3D cell culture, addressing critical workflow bottlenecks in purification and biomaterial design. The company demonstrates a strong focus on innovation through its proprietary platforms (PODS®, PeptiGel®, EVlution™) and maintains an active thought leadership presence via its technical blog. Positioned in the Cambridge biotech cluster, it leverages a global customer base while operating as a key supplier rather than a therapeutic developer.

Cell TherapyRegenerative MedicineBiologics

Technology Platform

Proprietary platforms include: PODS® for sustained protein delivery, PeptiGel® synthetic self-assembling peptide hydrogels for 3D cell culture, and the EVlution™ Tangential Flow Filtration system for extracellular vesicle purification.

Opportunities

The company is positioned in high-growth research sectors including extracellular vesicle/exosome research, 3D cell culture, and regenerative medicine.

Its tools address critical bottlenecks in scalability and reproducibility, offering significant expansion potential as these fields move towards clinical and diagnostic applications.

Global demand for advanced, defined research reagents continues to rise.

Risk Factors

Key risks include intense competition from large, established life science suppliers and other niche players, reliance on continued research funding in its core academic and biotech markets, and the challenge of driving adoption of new platforms against entrenched methods like ultracentrifugation for EV isolation.

Competitive Landscape

Cell Guidance Systems competes in the broad life science research tools market against giants like Thermo Fisher Scientific, Merck Millipore, and Corning. Its differentiation lies in specialized, proprietary platforms (PODS®, PeptiGel®, EVlution™) that address specific workflow challenges in advanced cell culture and EV research, carving out a niche among researchers seeking optimized performance over generic solutions.

More companies in United Kingdom →